Genetic mechanisms of mitral valve prolapse

Current Cardiovascular Risk Reports

Volumn 2, Issue 6, 2008, Pages 463-467

  Slaugenhaupt, Susan A ^a   Levine, Robert A ^b   Hagege, Albert A ^b   Jeunemaitre, Xavier ^b   Le Marec, Hervé ^b   Schott, Jean Jacques ^b   Probst, Vincent ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051859443     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-008-0082-4     Document Type: Article

References (44)

1. Levine RA, Stathogiannis E, Newell JB, et al.: Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol 1988, 11: 1010-1019.
2. Levine RA, Triulzi MO, Harrigan P, et al.: The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation 1987, 75: 756-767.
3. Levine RA, Handschumacher MD, Sanfilippo AJ, et al.: Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation 1989, 80: 589-598.
4. Perloff JK, Child JS: Mitral valve prolapse. Evolution and refinement of diagnostic techniques. Circulation 1989, 80: 710-711.
5. Freed LA Benjamin EJ, Levy D, et al.: Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002, 40: 1298-1304.
6. Freed LA, Levy D, Levine RA, et al.: Mitral valve prolapse and atrial septal aneurysm: an evaluation in the Framingham Heart Study. Am J Cardiol 2002, 89: 1326-1329.
7. Freed LA, Levy D, Levine RA, et al.: Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999, 341: 1-7.
8. Barber JE, Ratliff NB, Cosgrove DM 3rd, et al.: Myxomatous mitral valve chordae. I: Mechanical properties. J Heart Valve Dis 2001, 10: 320-324.
9. Baker PB, Bansal G, Boudoulas H, et al.: Floppy mitral valve chordae tendineae: histopathologic alterations. Hum Pathol 1988, 19: 507-512.
10. Tamura K, Fukuda Y, Ishizaki M, et al.: Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 1995, 129: 1149-1158.
11. Whittaker P, Boughner DR, Perkins DG, et al.: Quantitative structural analysis of collagen in chordae tendineae and its relation to floppy mitral valves and proteoglycan infiltration. Br Heart J 1987, 57: 264-269.
12. Fornes P, Heudes D, Fuzellier JF, et al.: Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol 1999, 8: 81-92.
13. Grande-Allen KJ, Griffin BP, Calabro A, et al.: Myxomatous mitral valve chordae. II: Selective elevation of glycosaminoglycan content. J Heart Valve Dis 2001, 10: 325-332; discussion 332-333.
14. Rabkin E, Aikawa M, Stone JR, et al.: Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001, 104: 2525-2532.
15. Brown CB, Boyer AS, Runyan RB, et al.: Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 1999, 283: 2080-2082.
16. Akiyama H, Chaboissier MC, Behringer RR, et al.: Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci U S A 2004, 101: 6502-6507.
17. Chang CP, Neilson JR, Bayle JH, et al.: A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118: 649-663.
18. Schulz RA, Yutzey KE: Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 2004, 266: 1-16.
19. de la Pompa JL, Timmerman LA, Takimoto H, et al.: Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 1998, 392: 182-186.
20. Ranger AM, Grusby MJ, Hodge MR, et al.: The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998, 392: 186-190.
21. Hurlstone AF, Haramis AP, Wienholds E, et al.: The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 2003, 425: 633-637.
22. Sugi Y, Ito N, Szebenyi G, et al.: Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev Biol 2003, 258: 252-263.
23. Galvin KM, Donovan MJ, Lynch CA, et al.: A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 2000, 24: 171-174.
24. Schilham MW, Oosterwegel MA, Moerer P, et al.: Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 1996, 380: 711-714.
25. Nesta F, Leyne M, Yosefy C, et al.: New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation 2005, 112: 2022-2030.
26. Keane MG, Pyeritz RE: Medical management of Marfan syndrome. Circulation 2008, 117: 2802-2813.
27. McDonnell NB, Gorman BL, Mandel KW, et al.: Echocardiographic findings in classical and hypermobile Ehlers-Danlos syndromes. Am J Med Genet A 2006, 140: 129-136.
28. Malfait F, De Paepe A: Molecular genetics in classic Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 2005, 139C: 17-23.
29. Hortop J, Tsipouras P, Hanley JA, et al.: Cardiovascular involvement in osteogenesis imperfecta. Circulation 1986, 73: 54-61.
30. Pyeritz RE, Weiss JL, Renie WA, Fine SL: Pseudoxanthoma elasticum and mitral-valve prolapse [letter]. N Engl J Med 1982, 307: 1451-1452.
31. Lebwohl MG, Distefano D, Prioleau PG, et al.: Pseudoxanthoma elasticum and mitral-valve prolapse. N Engl J Med 1982, 307: 228-231.
32. Plomp AS, Florijn RJ, Ten Brink J, et al.: ABCC6 mutations in pseudoxanthoma elasticum: an update including eight novel ones. Mol Vis 2008, 14: 118-124.
33. Disse S, Abergel E, Berrebi A, et al.: Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11. 2-p12. 1. Am J Hum Genet 1999, 65: 1242-1251.
34. Freed LA, Acierno JS Jr, Dai D, et al.: A locus for autosomal dominant mitral valve prolapse on chromosome 11p15. 4. Am J Hum Genet 2003, 72: 1551-1559.
35. Dietz HC, Cutting GR, Pyeritz RE, et al.: Marfan syndrome by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352: 337-339.
36. Neptune ER, Frischmeyer PA, Arking DE, et al.: Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003, 33: 407-411.
37. Ng CM, Cheng A, Myers LA, et al.: TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004, 114: 1586-1592.
38. Habashi JP, Judge DP, Holm TM, et al.: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312: 117-121.
39. Cohn R, van Erp C, Habashi J, et al: Angiotensin II type I receptor blockage attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 2007, 13: 204-210.
40. Ramirez F, Dietz HC: Fibrillin-rich microfibrils: structural determinants of morphogenetic and homeostatic events. J Cell Physiol 2007, 213: 326-330.
41. Kyndt F, Gueffet JP, Probst V, et al.: Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 2007, 115: 40-49.
42. Feng Y, Walsh CA: The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 2004, 6: 1034-1038.
43. Charitakis K, Basson CT: Degenerating heart valves: fill them up with filamin?Circulation 2007, 115: 2-4.
44. Sasaki A, Masuda Y, Ohta Y, et al.: Filamin associates with Smads and regulates transforming growth factor-beta signaling. J Biol Chem 2001, 276: 17871-17877.